Evidence map›Paper›PMID 38724684›Full record

ArticleNeurosurgical review2024

Glioblastoma: a comprehensive approach combining bibliometric analysis, Latent Dirichlet Allocation, and HJ-Biplot : Glioblastoma insights and trends: a 49-year bibliometric analysis.

Karime Montes-Escobar, Javier de la Hoz-M, Paul Castillo-Cordova, Julia Patricia Duran-Ospina, Rosalba Karen Bravo-Saltos, German Josuet Lapo-Talledo, Aline Siteneski

Abstract read
PubMed Publisher
In one paragraph

Article in Neurosurgical review, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Karime Montes-EscobarDepartamento de Matemáticas y Estadística, Faculta de Ciencias Básicas, Universidad Técnica de Manabí, Portoviejo, 130105, Ecuador.
Javier de la Hoz-MStatistics Department, University of Salamanca, Salamanca, 37007, Spain.
Paul Castillo-CordovaSOLCA Nucleus Loja, Loja, 110105, Ecuador.
Julia Patricia Duran-OspinaOptometry Carrer, Faculty of Health Sciences, Universidad Técnica de Manabí, Portoviejo, 130105, Ecuador.
Rosalba Karen Bravo-SaltosDepartamento de Matemáticas y Estadística, Faculta de Ciencias Básicas, Universidad Técnica de Manabí, Portoviejo, 130105, Ecuador.
German Josuet Lapo-TalledoSchool of Medicine, Faculty of Health Sciences, Universidad Técnica de Manabí, Portoviejo, 130105, Ecuador.
Aline SiteneskiSchool of Medicine, Faculty of Health Sciences, Universidad Técnica de Manabí, Portoviejo, 130105, Ecuador. aline.siteneski@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma is a common and aggressive malignant central nervous system tumor in adults. This study aims to evaluate and analyze the scientific results, collaboration countries, main research topics, and topics over time reported about glioblastoma. A bibliometric analysis of glioblastoma publications was performed mainly using R and Multbiplot software for author, journal, and resume. Associated statistic methods Latent Dirichlet Allocation (LDA) and HJ-Biplot. Inclusion criteria were research articles from the PubMed database published in English between 1973 and December 2022. A total of 64,823 documents with an annual growth rate of 8.27% indicates a consistent increase in research output over time. The results for the number of citations and significant publications showed Cancer Res, J Neuro-Oncol, and Neuro-Oncology are the most influential journals in the field of glioblastoma. The countries that concentrated research were the tumor United States, China, Germany, and Italy. Finally, there has been a marked growth in studies on prognosis and patient survival, therapies, and treatments for glioblastoma. These findings reinforce the need for increased global resources to address glioblastoma, particularly in underdeveloped countries. Glioblastoma research's exponential growth reflects sustained interest in early diagnosis and patient survival.

Indexed as

BibliometricsBiomedical ResearchBrain NeoplasmsGlioblastomaHumansBibliometricGlioblastomaPatient survivalTumor treatment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.